ATE153066T1 - Funktioneller dns-block und für hirudin kodierendes plasmid, transformierte hefe aud verfahren zur herstellung von hirudin. - Google Patents

Funktioneller dns-block und für hirudin kodierendes plasmid, transformierte hefe aud verfahren zur herstellung von hirudin.

Info

Publication number
ATE153066T1
ATE153066T1 AT87401649T AT87401649T ATE153066T1 AT E153066 T1 ATE153066 T1 AT E153066T1 AT 87401649 T AT87401649 T AT 87401649T AT 87401649 T AT87401649 T AT 87401649T AT E153066 T1 ATE153066 T1 AT E153066T1
Authority
AT
Austria
Prior art keywords
hirudin
gene
functional dna
aud
plasmid encoding
Prior art date
Application number
AT87401649T
Other languages
English (en)
Inventor
Nathalie Labat
Gerard Loison
Alain Balland
Yves Lemoine
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR868610090A external-priority patent/FR2601383B2/fr
Priority claimed from FR868616722A external-priority patent/FR2607516B2/fr
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of ATE153066T1 publication Critical patent/ATE153066T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT87401649T 1986-07-10 1987-07-10 Funktioneller dns-block und für hirudin kodierendes plasmid, transformierte hefe aud verfahren zur herstellung von hirudin. ATE153066T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR868610090A FR2601383B2 (fr) 1985-05-02 1986-07-10 Vecteurs perfectionnes d'expression de l'hirudine dans les levures, procede et produit obtenu
FR868616722A FR2607516B2 (fr) 1986-12-01 1986-12-01 Vecteurs perfectionnes d'expression d'un variant de l'hirudine dans les levures, procede et produit obtenu

Publications (1)

Publication Number Publication Date
ATE153066T1 true ATE153066T1 (de) 1997-05-15

Family

ID=26225387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87401649T ATE153066T1 (de) 1986-07-10 1987-07-10 Funktioneller dns-block und für hirudin kodierendes plasmid, transformierte hefe aud verfahren zur herstellung von hirudin.

Country Status (20)

Country Link
US (2) US5591640A (de)
EP (1) EP0252854B1 (de)
JP (1) JP2733602B2 (de)
KR (1) KR960013464B1 (de)
AT (1) ATE153066T1 (de)
AU (1) AU614933B2 (de)
BG (1) BG80504A (de)
CA (1) CA1341490C (de)
CZ (1) CZ278268B6 (de)
DE (1) DE3752063T2 (de)
DK (1) DK175195B1 (de)
ES (1) ES2103700T3 (de)
FI (1) FI96966C (de)
GR (1) GR3024368T3 (de)
HU (1) HU214236B (de)
MC (1) MC1834A1 (de)
NO (1) NO179489C (de)
PL (1) PL154118B1 (de)
PT (1) PT85296B (de)
RU (1) RU1776276C (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
GB8809860D0 (en) * 1988-04-26 1988-06-02 Ciba Geigy Ag Process for production of polypeptides
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche
FR2645174B1 (fr) * 1989-03-31 1994-01-07 Transgene Sa Souches de levure ameliorees pour la production de proteines heterologues matures en particulier d'hirudine et procede de preparation d'hirudine correspondant
US5879926A (en) * 1989-03-31 1999-03-09 Transgene S.A. Yeast strains for the production of mature heterologous proteins, especially hirudin
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
GB9015825D0 (en) * 1990-07-18 1990-09-05 Ciba Geigy Ag In vitro processing of fusion proteins
US6514730B1 (en) 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
DE69329540T2 (de) * 1992-09-04 2001-06-07 Novartis Ag, Basel Verfahren zur Herstellung von Proteaseinhibitoren
TW282490B (de) * 1992-12-15 1996-08-01 Ciba Geigy Ag
US5712114A (en) * 1995-06-06 1998-01-27 Basf Aktiengesellschaft Compositions for expression of proteins in host cells using a preprocollagen signal sequence
WO1999037793A1 (en) * 1998-01-23 1999-07-29 Novo Nordisk A/S Process for making desired polypeptides in yeast
KR100949722B1 (ko) 2002-08-12 2010-03-25 에이펙셀 (주) 마이크로 초미립 분쇄기
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
NO840200L (no) * 1983-01-28 1984-07-30 Cefus Corp Glukoamylase cdna.
JPS6041487A (ja) * 1983-04-25 1985-03-05 ジエネンテツク・インコ−ポレイテツド 酵母発現系でのアルフア因子配列の使用
DE3586333T2 (de) * 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE3583361D1 (de) * 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation

Also Published As

Publication number Publication date
EP0252854B1 (de) 1997-05-14
RU1776276C (ru) 1992-11-15
PT85296A (pt) 1988-07-29
FI96966B (fi) 1996-06-14
ES2103700T3 (es) 1997-10-01
DK355887A (da) 1988-01-11
KR960013464B1 (ko) 1996-10-05
BG80504A (bg) 1993-12-24
DE3752063T2 (de) 1997-12-04
HU214236B (hu) 1998-03-02
AU614933B2 (en) 1991-09-19
DK355887D0 (da) 1987-07-09
CZ278268B6 (en) 1993-11-17
US5902735A (en) 1999-05-11
KR880007727A (ko) 1988-08-29
DE3752063D1 (de) 1997-06-19
DK175195B1 (da) 2004-07-05
FI873068A7 (fi) 1988-01-11
PT85296B (pt) 1995-05-31
NO179489B (no) 1996-07-08
PL154118B1 (en) 1991-07-31
AU7536687A (en) 1988-01-14
CZ527787A3 (en) 1993-08-11
MC1834A1 (fr) 1988-06-03
EP0252854A1 (de) 1988-01-13
NO872878D0 (no) 1987-07-10
CA1341490C (fr) 2005-08-30
JP2733602B2 (ja) 1998-03-30
GR3024368T3 (en) 1997-11-28
PL266756A1 (en) 1988-06-23
NO179489C (no) 1996-10-16
NO872878L (no) 1988-01-11
FI96966C (fi) 1996-09-25
HUT44616A (en) 1988-03-28
US5591640A (en) 1997-01-07
FI873068A0 (fi) 1987-07-10
JPS6485082A (en) 1989-03-30

Similar Documents

Publication Publication Date Title
DE3752063D1 (de) Funktioneller DNS-Block und für Hirudin kodierendes Plasmid, transformierte Hefe aud Verfahren zur Herstellung von Hirudin.
ATE547532T1 (de) Verfahren zur erzeugung von hochgradig diversen bibliotheken
ATE118549T1 (de) Verfahren zur synthese von ribonukleinsäure (rns).
ATE106948T1 (de) Verfahren zur amplifizierung von nukleinsäuren.
EP0316018A3 (de) Modifikation von DNS-Sequenzen
ATE191510T1 (de) Selektive restriktionsfragmentenamplifikation: generelles verfahren für dns-fingerprinting
BR0005091A (pt) Sequências de nucleotìdio codificando para o gene poxb
DE3583361D1 (de) Verfahren zur herstellung von thrombin-inhibitoren.
ATE348091T1 (de) Verfahren zur rückgewinnung von acrolein oder propionaldehyd aus verdünnten wässrigen strömen
ATE8142T1 (de) Verfahren zur herstellung von isosorbid-5-nitrat.
EP1136559A3 (de) Für das dapC-Gen kodierende Nukleotidsequenzen und Verfahren zur Herstellung von L-Lysin
DE3762044D1 (de) Verfahren zur herstellung von chlorcarbonsaeurechloriden.
ATE215524T1 (de) Verfahren zur herstellung und reinigung von komplexestern
ES8205429A1 (es) Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de fibro- blastos humanos.
ATE103329T1 (de) Verfahren zur herstellung von hgiairestriktionsendonuklease und -methylase.
EP0845470A3 (de) Verfahren zur kontinuierlichen Herstellung von Carbonoyloxysilanen
ATE166643T1 (de) Verfahren zur reinigung von rohem caprolactam
DE69424065D1 (de) Verfahren zur herstellung von zwischenprodukten, die für die herstellung von retroviral-protease hemmenden verbindungen verwendbar sind
DE3577723D1 (de) Transfer-vektor.
EP1118666A3 (de) Für das ptsH-Gen codierende Nukleotidsequenzen aus Corynebacterium glutamicum
DE3853143D1 (de) Verfahren zur Herstellung von AccI-Restriktionsendonuklease und -methylase.
ATE202070T1 (de) Verfahren zur herstellung von 3-hydroxy-2- methylbenzoesäure und 3-acetoxy-2- methylbenzoesäure
EP1106622A3 (de) Neue für das pfkA-Gen codierende Nukleotidsequenzen
DE3669311D1 (de) Verfahren zur herstellung von hydrochinon.
ATE81496T1 (de) Verfahren zur reinigung von dihydroxybiphenylen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time